SEC Info - 4D Pharma plc - ‘F-4/A’ on 1/8/21

SEC Info℠

Home

Help

Please Sign In

4D Pharma plc – ‘F-4/A’ on 1/8/21 – ‘EX-23.1’

On: Friday, 1/8/21, at 4:33pm ET · Accession #: 1104659-21-2497 · File #: 333-250986

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/08/21  4D Pharma plc                     F-4/A                  7:12M                                    Toppan Merrill/FA

Pre-Effective Amendment to Registration Statement by a Foreign Issuer – Securities for a Merger — Form F-4
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: F-4/A       Pre-Effective Amendment to Registration Statement   HTML   3.05M 
                by a Foreign Issuer - Securities for a Merger                    
 2: EX-9.2      Voting Trust Agreement                              HTML     42K 
 3: EX-10.1     Material Contract                                   HTML     81K 
 5: EX-10.11    Material Contract                                   HTML     15K 
 4: EX-10.2     Material Contract                                   HTML    290K 
 6: EX-23.1     Consent of Expert or Counsel                        HTML      6K 
 7: EX-23.2     Consent of Expert or Counsel                        HTML      6K

‘EX-23.1’ — Consent of Expert or Counsel

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the use in this Amendment No. 1 to the Registration Statement (No.333-250986) on Form F-4 of 4D pharma plc of our report dated November 25, 2020, relating to the consolidated financial statements of 4D pharma plc, appearing in the Proxy Statement/Prospectus, which is part of this Registration Statement.

We also consent to the reference to our firm under the heading "Experts" in such Proxy Statement/Prospectus.

/s/ RSM US LLP

Boston, MA

January 7, 2021

C: 1

Dates Referenced Herein and Documents Incorporated by Reference

This ‘F-4/A’ Filing	Date	Other Filings

Filed on:	1/8/21	CORRESP
	1/7/21
	11/25/20	F-4
		List all Filings

10 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/31/22  4D Pharma plc                     20-F       12/31/21   82:13M                                    M2 Compliance LLC/FA
10/07/21  4D Pharma plc                     F-1/A                 90:15M                                    M2 Compliance LLC/FA
 9/14/21  4D Pharma plc                     F-1         9/13/21   76:9.2M                                   M2 Compliance LLC/FA
 4/30/21  4D Pharma plc                     20-F/A     12/31/20   75:6.9M                                   M2 Compliance LLC/FA
 4/23/21  4D Pharma plc                     F-1                   73:8.4M                                   M2 Compliance LLC/FA
 4/02/21  4D Pharma plc                     20-F       12/31/20   77:7.1M                                   M2 Compliance LLC/FA
 2/24/21  4D Pharma plc                     F-4/A                  4:11M                                    Toppan Merrill/FA
 2/19/21  4D Pharma plc                     F-4/A                  4:11M                                    Toppan Merrill/FA
 2/16/21  4D Pharma plc                     F-4/A                 12:12M                                    Toppan Merrill/FA
 1/28/21  4D Pharma plc                     F-4/A                 17:100M                                   Toppan Merrill/FA

1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/25/20  4D Pharma plc                     F-4                    8:12M                                    Toppan Merrill/FA

↑Top

Filing Submission 0001104659-21-002497 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)